BRD3 antibody - N-terminal region
Product Sizes
25ul
£177.00
ARP38939-T100-25UL
100 ul
£373.00
ARP38939-T100-100UL
About this Product
- SKU:
- ARP38939-T100
- Additional Names:
- ORFX; RING3L
- Clonality:
- Polyclonal
- Concentration:
- 1.0 mg/ml
- Extra Details:
- This gene was identified based on its homology to the gene encoding the RING3 protein; a serine/threonine kinase. The gene localizes to 9q34; a region which contains several major histocompatibility complex (MHC) genes. BRD3 is ubiquitously expressed in human adult and fetal tissues. BRD3 is markedly expressed in undifferentiated ES cells; whereas the expression was reduced upon endothelial differentiation. BRD3 plays a role in regulation of cell proliferation by allowing cells to enter the proliferative phase of the angiogenic process.BRD3 is also involved in bladder cancer.
- Gene Details:
- Bromodomain containing 3
- Host:
- Rabbit
- Immunogen:
- The immunogen is a synthetic peptide directed towards the N terminal region of human BRD3
- Molecular Weight:
- 61kDa
- Purification:
- Protein A purified
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- For short term use; store at 2-8C up to 1 week. For long term storage; store at -20C in small aliquots to prevent freeze-thaw cycles.
- Supplier:
- Aviva Systems Biology
- Type:
- Antibodies: Polyclonal Antibody
- Manufacturer's Data Sheet:html_datasheet.php
